Search Results 811-820 of 25582 for treatment resistant depression
A Study of the Combination of ACP-196 and Pembrolizumab in Subjects with Platinum-Refractory Metastatic Bladder Cancer · Share · Facebook · Twitter.
Clinical Trials · Dose-Escalation Study of cevostamab (BFCR4350A) in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM) · More about research at ...
The purpose of this study is to assess overall response rate, including complete and partial response, of daratumumab in patients with relapsed or refractory ...
This genetic condition causes tumors on nerve tissue. Surgery and other therapies can manage symptoms.
TAK-981 is being tested in combination with anti-CD38 monoclonal antibodies to treat participants who have relapsed or refractory multiple myeloma.
Sudden hair loss can signal an underlying medical condition that requires treatment. ... Make your tax-deductible gift and be part of the cutting-edge research ...
Clinical Trials · A Study of Acalabrutinib and Vistusertib in Subjects With Relapsed/Refractory B-cell Malignancies · More about research at Mayo Clinic · Mayo ...
About this study. This phase II trial studies how well lenalidomide and dexamethasone work in treating patients with relapsed or refractory multiple myeloma ...
By condition, treatment or drug name. Search tips. A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer. Print ...
Amitriptyline is used to treat symptoms of depression. It works on the central nervous system (CNS) to increase levels of certain chemicals in the brain. This ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can go twice as far to fight cancer.